BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37481242)

  • 1. Bone Marrow Quality Index: A Predictor of Acute Graft-versus-Host Disease in Hematopoietic Stem Cell Transplantation for Thalassemia.
    Agarwal RK; Dhanya R; Sedai A; Ankita K; Parmar L; Ramprakash S; Sandeep ; Trivedi D; Shah V; Bhat N; Reddy M; R N; Faulkner L
    Transplant Cell Ther; 2023 Nov; 29(11):711.e1-711.e6. PubMed ID: 37481242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.
    Chu R; Brazauskas R; Kan F; Bashey A; Bredeson C; Camitta B; Chiang KY; Frangoul H; Gale RP; Gee A; George B; Goldman FD; Gross TG; Gupta V; Hale GA; Isola L; Ispizua AU; Lazarus H; Marsh J; Russell J; Sabloff M; Waller EK; Eapen M
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1018-24. PubMed ID: 21034842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation.
    Ji SQ; Chen HR; Xun CQ; Wang HX; Pan SP; Xiao MH
    Clin Transplant; 2001 Oct; 15(5):317-23. PubMed ID: 11678957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and graft characteristics in pediatric hematopoietic stem cell transplantation: Effect of granulocyte-colony stimulating factor priming.
    Fettah A; Özbek N; Azık F; Tavil B; Özgüner M; Avcı Z; Işık P; Yaralı N; Uçkan D; Tunç B
    Transfus Apher Sci; 2015 Jun; 52(3):332-8. PubMed ID: 25779226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
    Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ
    Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanism for granulocyte-colony stimulating factor in the prevention of graft-versus-host disease in combined bone marrow and peripheral blood transplantation for hematological malignancies: the composition in collection.
    Zhang C; Zhang X; Chen XH
    Transfus Apher Sci; 2013 Feb; 48(1):3-9. PubMed ID: 23279971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone.
    Wen J; Haque Q; Pei F; Chen L; Ruan Y; Liu X; He Y; Feng X; Li C; Wu X
    Acta Haematol; 2018; 140(1):20-29. PubMed ID: 30071526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration of leukemic granulocyte colony-stimulating factor to donors: the changes in donor bone marrow cell composition and the transplantation outcome].
    Ji S; Chen H; Wang H; Yan H; Pan S
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):834-7. PubMed ID: 16206675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation.
    Zhao XY; Xu LL; Lu SY; Huang XJ
    Eur J Immunol; 2011 Feb; 41(2):514-26. PubMed ID: 21268020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
    Lacan C; Lambert J; Forcade E; Robin M; Chevallier P; Loron S; Bulabois CÉ; Orvain C; Ceballos P; Daguindau E; Charbonnier A; Chalandon Y; Bernard M; Simand C; Rubio MT; Turlure P; Maertens J; Huynh A; Loschi M; Bay JO; Guillerm G; Alani M; Castilla-Llorente C; Poiré X; Chantepie S; Maillard N; Beguin Y; Marçais A; Cornillon J; Malfuson JV; Maury S; Meuleman N; Villate A; Bekadja MA; Walter-Petrich A; Jacque N; Srour M; Devillier R; Nguyen S
    J Hematol Oncol; 2024 Jan; 17(1):2. PubMed ID: 38185663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
    Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
    Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.
    Morton J; Hutchins C; Durrant S
    Blood; 2001 Dec; 98(12):3186-91. PubMed ID: 11719353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences.
    Kim H; Kang HJ; Lee JW; Park KD; Shin HY; Ahn HS
    Ann Hematol; 2012 May; 91(5):751-758. PubMed ID: 22076065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation.
    Isola L; Scigliano E; Fruchtman S
    Biol Blood Marrow Transplant; 2000; 6(4A):428-33. PubMed ID: 10975511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.
    Huang XJ; Han W; Xu LP; Chen YH; Liu DH; Lu J; Chen H; Zhang YC; Jiang Q; Liu KY; Lu DP
    Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
    Chen HR; Ji SQ; Wang HX; Yan HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):340-6. PubMed ID: 12513770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with G-CSF mobilized bone marrow plus peripheral blood stem cells grafts without T cell depletion: a single center report of 29 cases.
    Wang HX; Yan HM; Wang ZD; Xue M; Liu J; Guo ZK
    Leuk Lymphoma; 2012 Apr; 53(4):654-9. PubMed ID: 21929286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.